Table 1. Patient characteristics.
| Characteristic | Total (n = 517) | Non-AF (n = 477) | AF (n = 40) | P | |
|---|---|---|---|---|---|
| Age, yrs | 57.2 ± 12.4 | 57.0 ± 12.3 | 60.2 ± 13.7 | 0.119 | |
| Sex, female | 77 (14.9) | 71 (14.9) | 6 (15.0) | 0.984 | |
| BMI, kg/m2 | 25.7 ± 3.3 | 25.7 ± 3.3 | 25.2 ± 2.6 | 0.337 | |
| SBP, mmHg | 128.1 ± 18.7 | 128.6 ± 19.0 | 122.5 ± 14.8 | 0.048 | |
| DBP, mmHg | 80.3 ± 13.4 | 80.3 ± 13.3 | 79.2 ± 13.9 | 0.595 | |
| Heart rate, bpm | 79.1 ± 13.1 | 78.9 ± 13.1 | 81.3 ± 13.6 | 0.258 | |
| Smoking | 275 (53.2) | 258 (54.1) | 17 (42.5) | 0.158 | |
| Hypertension | 231 (44.7) | 216 (45.3) | 15 (37.5) | 0.342 | |
| Diabetes mellitus | 128 (24.8) | 120 (25.2) | 8 (20.0) | 0.468 | |
| Stroke | 61 (11.8) | 57 (12.0) | 4 (10.0) | 0.911 | |
| IRA | |||||
| LCX | 104 (20.1) | 98 (20.6) | 6 (15.0) | 0.401 | |
| LAD | 256 (49.5) | 243 (50.9) | 13 (32.5) | 0.025 | |
| RCA | 153 (29.6) | 133 (27.9) | 20 (50.0) | 0.003 | |
| Others | 4 (0.8) | 3 (0.6) | 1 (2.5) | 0.276 | |
| Killip class | 0.862 | ||||
| I | 476 (92.1) | 439 (92.0) | 37 (92.5) | ||
| II | 17 (3.3) | 15 (3.1) | 2 (5.0) | ||
| III | 6 (1.2) | 6 (1.3) | 0 (0.0) | ||
| IV | 18 (3.5) | 17 (3.6) | 1 (2.5) | ||
| Medication | |||||
| Statins | 492 (95.2) | 456 (95.6) | 36 (90.0) | 0.230 | |
| Dapagliflozin | 140 (27.1) | 130 (27.3) | 10 (25.0) | 0.758 | |
| ACEI/ARB | 323 (62.5) | 301 (63.1) | 22 (55.0) | 0.309 | |
| β-blockers | 437 (84.5) | 401 (84.1) | 36 (90.0) | 0.319 | |
| Spironolactone | 47 (9.1) | 41 (8.6) | 6 (15.0) | 0.286 | |
| Laboratory indicators | |||||
| Total cholesterol, mmol/L | 4.34 ± 1.03 | 4.34 ± 1.04 | 4.30 ± 0.84 | 0.814 | |
| Triglycerides, mmol/L | 1.77 ± 1.22 | 1.77 ± 1.21 | 1.84 ± 1.33 | 0.711 | |
| HDL-C, mmol/L | 0.94 ± 0.23 | 0.94 ± 0.23 | 0.95 ± 0.23 | 0.888 | |
| LDL-C, mmol/L | 2.76 ± 0.87 | 2.76 ± 0.88 | 2.68 ± 0.82 | 0.583 | |
| FBG, mmol/L | 6.51 ± 2.56 | 6.50 ± 2.59 | 6.69 ± 2.09 | 0.648 | |
| eGFR, mL/min/1.73 m2 | 108.9 ± 15.2 | 109.1 ± 14.9 | 106.1 ± 17.5 | 0.230 | |
| Peak hs-TnT, ng/L | 2478.0 (886.7, 5319.0) | 2345.0 (866.0, 5118.0) | 4676.5 (1892.5, 8159.8) | 0.011 | |
| Peak NT-proBNP, pg/mL | 1055.0 (510.0, 2143.2) | 998.0 (495.0, 1986.0) | 2174.0 (1262.5, 3190.7) | <0.001 | |
| Peak hs-CRP, mg/L | 13.9 (4.4, 35.9) | 13.8 (4.3, 35.1) | 16.1 (7.6, 44.8) | 0.398 | |
Data are presented as count (%) for categorical variables and median (Q1, Q3) or mean ± standard deviation for continuous variables.
AF = atrial fibrillation, BMI = body mass index, SBP = systolic blood pressure, DBP = diastolic blood pressure, IRA = infarct-related artery, LCX = left circumflex artery, LAD = left atrial diameter, RCA = right coronary artery, Others = left main coronary artery and intermediate branch, ACEI = angiotensin-converting-enzyme inhibitor, ARB = angiotensin II receptor blocker, HDL-C = high-density leptin cholesterol, LDL-C = low-density leptin cholesterol, FBG = fasting blood glucose, eGFR = estimated glomerular filtration rate, hs-TnT = high sensitivity troponin T, NT-proBNP = N-terminal pro-B-type natriuretic peptide, hs-CRP = high sensitivity C-reactive protein